Literature DB >> 7494002

Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor.

S Ashikari1, H Habuchi, K Kimata.   

Abstract

Proteoglycans from rat liver had the ability to bind hepatocyte growth factor (HGF). Digestion of the proteoglycans with heparitinase resulted in the complete loss of the activity, while the digestion with chondroitinase ABC had no effect. Heparan sulfate (HS)-conjugated gel also bound HGF, and the binding was competitively inhibited by heparin and bovine liver HS, but not by Engelbreth-Holm-Swarm sarcoma HS, pig aorta HS, or other glycosaminoglycans, suggesting the specific structural domain in HS for the binding of HGF. Among limited digests with heparitinase I of bovine liver HS, octasaccharide is the minimal size to bind HGF. Comparison of the disaccharide unit compositions revealed a marked difference in IdoA(2SO4)-GlcNSO3(6SO4) unit between the bound and unbound octasaccharides. The contents of this disaccharide unit were calculated to be 2 mol/mol for the bound octasaccharide but 1 mol/mol for the unbound one. Considering both the substrate specificity and properties of heparitinase I, the above results suggest that the bound octasaccharide should contain two units of IdoA(2SO4)-GlcNSO3(6SO4) contiguously or alternately in the vicinity of the reducing end. The bound decasaccharide was more than 20 times as active as the unbound one with regard to the ability to release HGF bound to rat liver HS proteoglycan. The ability was comparable to the one-fourth of that of heparin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7494002     DOI: 10.1074/jbc.270.49.29586

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.

Authors:  A Cantón; R Burgos; C Hernández; C Mateo; R M Segura; J Mesa; R Simó
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

2.  Spatiotemporal distribution of heparan sulfate epitopes during murine cartilage growth plate development.

Authors:  Ronald R Gomes; Toin H Van Kuppevelt; Mary C Farach-Carson; Daniel D Carson
Journal:  Histochem Cell Biol       Date:  2006-07-12       Impact factor: 4.304

Review 3.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 4.  Syndecans: multifunctional cell-surface co-receptors.

Authors:  D J Carey
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

5.  Lactoferrin regulates the activity of heparin proteoglycan-bound mast cell chymase: characterization of the binding of heparin to lactoferrin.

Authors:  G Pejler
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

6.  Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.

Authors:  M Safran; M Eisenstein; D Aviezer; A Yayon
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

Review 7.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

8.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

Review 9.  Therapeutically targeting protein-glycan interactions.

Authors:  A Rek; E Krenn; A J Kungl
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

10.  A novel mechanism of sequestering fibroblast growth factor 2 by glypican in lipid rafts, allowing skeletal muscle differentiation.

Authors:  Jaime Gutiérrez; Enrique Brandan
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.